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To examine the capability of MRI texture analysis to differentiate the primary site of 
origin of brain metastases following a radiomics approach. 
 
Methods: 
Sixty-seven untreated brain metastases (BM) were found in 3D T1-weighted MRI of 
38 patients with cancer: 27 from lung cancer, 23 from melanoma and 17 from breast 
cancer. These lesions were segmented in 2D and 3D to compare the discriminative 
power of 2D and 3D texture features. The images were quantized using different 
number of gray-levels to test the influence of quantization. Forty-three rotation-
invariant texture features were examined. Feature selection and random forest 
classification were implemented within a nested cross-validation structure. 
Classification was evaluated with the area under receiver operating characteristic 
curve (AUC) considering two strategies: multiclass and one-versus-one. 
 
Results: 
In the multiclass approach, 3D texture features were more discriminative than 2D 
features. The best results were achieved for images quantized with 32 gray-levels 
(AUC = 0.873 ± 0.064) using the top four features provided by the feature selection 
method based on the p-value. In the one-versus-one approach, high accuracy was 
obtained when differentiating lung cancer BM from breast cancer BM (4 features, 
AUC = 0.963 ± 0.054) and melanoma BM (8 features, AUC = 0.936 ± 0.070) using 
the optimal dataset (3D features, 32 gray-levels). Classification of breast cancer and 






Volumetric MRI texture features can be useful to differentiate brain metastases from 
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• Texture analysis is a promising source of biomarkers for classifying brain 
neoplasms. 
• MRI texture features of brain metastases could help identifying the primary 
cancer. 
• Volumetric texture features are more discriminative than traditional 2D texture 
features. 
• The number of gray-levels used to quantize images influence the results. 







ABBREVIATIONS AND ACRONIMS: 
ANOVA = Analysis of variance 
AUC = Area under receiver operating characteristics curve 
BM = Brain metastases 
CM = Confusion matrix 
CV = Cross-validation 
GLCM = Gray-level co-occurrence matrix 
GLRLM = Gray-level run-length matrix 
GLSZM = Gray-level size zone matrix 
LGOCV = Leave-group-out cross-validation 
NGL = Number of gray-levels 
NGTDM = Neighborhood gray-tone difference matrix 
RF = Random forest 









Brain metastases (BM) are the most common neoplasms of the central 
nervous system in adults. The prognosis of patients diagnosed with these lesions is 
poor: their median survival is limited to months even for patients under treatment [1–
4]. The incidence of BM is unavailable although some studies reported that they 
occur in 9–17% of patients with cancer [1, 5]. However, these rates are currently 
increasing due to improved imaging techniques for diagnosis and prolonged survival 
from primary cancers, among other reasons [5]. 
The primary tumors that metastasize more frequently to the brain are those 
originated in lung (≥50%), breast (15–25%) and skin (melanoma) (5–20%) [3]. 
However, some studies indicate that there is a percentage of patients (2–14%) 
presenting BM as the first manifestation of an unknown primary tumor [5]. These 
patients are subjected to invasive neuropathological procedures and imaging 
evaluations, and sometimes the origin of the BM remains undiagnosed at the time of 
death [6–10]. Therefore, there is a clear need to detect the primary tumor in a fast, 
reliable and non-invasive way, as even neuropathological strategies can offer 
contradictory results [10]. 
In the past years, radiomics analysis has been proved to be a valuable 
methodology to increase precision in diagnosis or to predict treatment response in 
cancer research [11–13]. Radiomics is defined as the analysis of a large amount of 
data extracted from medical images to increase the power of decision support tools 
[11, 12]. Radiomics involves processes like image acquisition, image segmentation 
or data mining, but the focus of radiomics is the extraction of features that describe 
quantitatively the image [14]. To this end, texture analysis (TA) has been proved to 





application of mathematical methods to evaluate the gray-level patterns and pixel 
interrelationships within an image [15]. The main reason behind using TA to 
characterize tissues in medical images is that TA quantifies the intrinsic 
heterogeneous properties that are usually imperceptible to the human eye. Some TA 
methods have been successfully applied in neurologic disorders studies, including 
brain lesions like BM [16–22], using MRI as the main imaging technique. Particularly, 
contrast-enhanced T1-weigted MRI was the main sequence in these studies as it is 
employed for initial brain tumor detection and contains abundant diagnostic 
information [22, 23].  
Some considerations have to be taken before performing TA. Preprocessing of 
the image region should be analyzed to minimize the effects of MRI acquisition 
protocols. Interpolation, normalization or quantization are preprocessing techniques 
commonly used to improve texture discrimination [24]. In particular, the quantization 
process has been demonstrated to have a substantial impact on the texture profile of 
medical images [25, 26], so it is recommended to optimize the number of gray-levels. 
Also, 3D TA should be considered instead of traditional 2D TA because volumetric 
TA allows to capture tissue heterogeneity more accurately [27]. 
The purpose of this work was to identify the primary site of origin of BM using 
MRI texture features in combination with a random forest (RF) classifier based on the 
radiomics practice. Our hypothesis was that TA could help to find differences 
between BM from different primary sites of origin, considering that it is not possible to 








MATERIALS AND METHODS 
Patients 
This retrospective, single-center study was approved by the Institutional 
Review Board and all subjects provided written informed consent. 
Patients showing single or multiple BM were consecutive reviewed by an 
expert neuroradiologist (20 years-experience). Inclusion criteria comprised: (1) 
pathologically confirmed lung cancer, breast cancer or melanoma and only one 
single primary tumor; (2) no previous treatment, biopsy or surgical resection on BM; 
(3) all BM confirmed by imaging and clinical follow-up and (4) no clear qualitative 
and/or systematic differences on T1-weighted images of the BM to identify the 
primary cancer (ie, hyperintense in every melanoma case). Exclusion criteria were as 
follows (1) small metastases (longest diameter < 9 mm) as TA cannot capture texture 
information properly in small regions [24]; (2) more than 3 BM per patient; (3) multiple 
BM were situated in different brain areas. 
The first thirty-eight patients (22 men and 16 women, mean age 60.05 years, 
age range 24–74 years) who complied with inclusion criterion 
and not with exclusion criteria were selected between December 2013 and April 2016 
were included. Sixty-seven baseline BM were found in these patients: 27 derived 
from lung cancer, 23 from melanoma and 17 from breast cancer. Figure 1 shows an 
example of these types of BM. 
 
Imaging Protocol 
Imaging was performed using a 1.5T MRI scanner (Optima MR450w; GE 
Medical Systems, Milwaukee, WI, USA). The MRI protocol included three-





weighted brain images, according to standardized protocol [28]. Images were 
acquired without magnetization transfer, after intravenous administration of a single-
dose of gadobenate dimeglumine (0.1 mmol/kg, MultiHance, Bracco; Milan, Italy) 
with a 6 minutes delay. All the BM were scanned using the same imaging parameters 
since changing these parameters may lead to differences in TA performance [29, 30]: 
repetition time/echo time (TR/TE) of 8.5/2.2 ms; flip angle of 12º; matrix size of 
256×256; pixel size of 0.98×0.98 mm2; and slice thickness of 1.3 mm. Partial bias 
field correction in raw data was performed via the on-scanner “pre-scan normalize” 
option. No on-scanner gradient distortion correction was applied. As no diffusion 
weighted-sequences were used in this work, post processing bias field correction 
was not applied 
 
Regions of Interest 
Segmentation of the BM in 2D and 3D was performed using a software tool 
developed specifically for this study in MATLAB (R2015b; The MathWorks Inc., 
Natick, MA, USA). To segment each BM in 2D, the axial slice of the 3D T1-weighted 
image showing the most solid lesion component was manually segmented by an 
expert neuroradiologist (20 years-experience). To segment each BM in 3D, all the 
axial slices of the 3D T1-weighted image showing tissue of the same lesion were 
segmented using a semiautomatic method based on the Chan-Vese algorithm [31] 
that takes the manually segmented 2D lesion as the initial contour. Each 3D 
segmented lesion was revised by the expert. The longest diameters of the volumetric 
lesions were normally distributed without statistical differences (One-way ANOVA F-
test, p>0.05, p=0.314) between the three classes, with mean ± standard deviation of 
24.22 ± 10.67 mm (lung cancer BM), 19.92 ± 7.93 mm (melanoma BM) and 22.08 ± 






 Prior to feature extraction, some preprocessing techniques were applied to 
improve texture discrimination. Firstly, the MRI regions were normalized using the μ ± 
3σ method to enhance the differences between classes [32]. 
 Gray-level quantization (reduction of the levels of gray used to represent the 
image) was also applied to reduce the computational time and to improve the signal-
to-noise ratio of the texture outcome [33]. In particular, different numbers of gray-
levels (NGL) were tested (8, 16, 32, 64 and 128) to study the influence of the 
quantization process in the discriminative power of the features. 
Finally, volumetric regions were isotropically resampled to the in-plane 
resolution (voxel size = 0.98×0.98×0.98 mm3) using cubic interpolation to ensure the 
conservation of scales and directions when extracting the 3D features [27]. 
 
Feature Extraction 
Feature extraction was performed using the Radiomics MATLAB package [34]. 
Forty-three texture-based features derived from five statistical methods were 
computed. Three features were extracted from the intensity histogram (first-order 
statistics) and the other 40 features were extracted from the following higher-order 
statistical methods: gray-level co-occurrence matrix (GLCM), gray-level run-length 
matrix (GLRLM), gray-level size-zone matrix (GLSZM) and neighborhood gray-tone 
difference matrix (NGTDM). Table 1 summarizes the features described in [34]. 
The proposed features met the criterion of rotation invariance to achieve 
texture parameters that are not dependent on the orientation of the brain in the 
images. To this end, only one GLCM, GLRLM, GLSZM and NGTDM per lesion was 





2D space (0°, 45°, 90°, 135°) were averaged equally. For 3D TA, the neighboring 
properties of voxels in the 13 directions of the 3D space were averaged differently to 
take into account discretization length differences [34]. 
Finally, 10 different datasets of texture features were obtained: five datasets, 
one per NGL, extracted from the 2D regions and five datasets, one per NGL, from 
the 3D regions. All features were standardized to zero mean and unit variance to 
avoid model building being affected by the differences in the feature scales [35]. A 
summary of the procedure followed to obtain the datasets is illustrated in Figure 1.  
 
Strategies for Multiclass Classification 
As mentioned before, three classes of BM were considered according to the 
primary site of origin (lung cancer, breast cancer and melanoma). Random forest 
(RF) is a well-known ensemble learning method of the decision trees family that 
usually provides excellent classification results, especially when dealing with 
multiclass problems [36, 37]. Therefore, the RF classifier was chosen as the 
predictive model to evaluate the discriminative power of features. The number of 
trees in the RF model was set to 250 and the number of random variables used as 
candidates at each split (mtry) was chosen from mtry ∈ {2, 3, 4, ..., 14, 15} in the 
parameter tuning process. 
In the first stage of the study, the 10 datasets were analyzed separately using 
a purely multiclass approach with RF. The resulting statistical metrics derived from 
the model performance of each dataset were compared to identify the dataset of 
features that provided the best classification results. Afterwards, the optimal dataset 
was evaluated using a one-versus-one strategy to examine the capability of these 






Considering the small sample size of our datasets, we decided to evaluate the 
performance of the classifier within a nested cross-validation (CV) structure (Figure 
2). Good estimates of the model performance can be achieved using the validation 
data when the number of samples is not large [38]. The outer resampling loop of the 
nested CV structure was used to optimize the number of features and the inner 
resampling loop was used to tune the model parameter (mtry). 
Leave-group-out CV (LGOCV) was applied in the outer resampling loop. This 
resampling method randomly divides each dataset into training and test sets N times, 
forming N groups. Each group is examined independently: the samples of the training 
set of a group are used to build the model and then this model is evaluated using the 
samples of the test set of the same group. Then, the classification results provided by 
the estimates of all groups are averaged. A total of N=100 groups were used to 
reduce the variance of the CV results [38]. In each group, 25% of the samples were 
randomly selected as test set and the remaining 75% were used as training set. 
Brain metastases from the same patient were treated indistinctively in the 
resampling step to avoid selection bias. To support this decision, a Pearson 
correlation test was performed to measure the linear dependence between random 
pairs of vectors of texture features from BM of the same patient (|r| = 0.431 ± 0.296) 
and BM from different patients (|r| = 0.424 ± 0.248). No statistical difference was 
found between the two groups (Welch’s t-test: p=0.917), suggesting that BM from the 
same patient are correlated in the same way that BM of different patients can be. 
For the feature selection step, a filter method based on the p-value was 
employed to obtain a ranking of features with the most discriminative power. This 





analyzing the relation between features [39]. The p-values were obtained with the 
One-way Analysis of Variance (ANOVA) F-test for the multiclass strategy and the 
Welch’s t-test for the one-versus-one strategy. The RF variable importance computed 
in the training process was also tested as a feature selection method to compare the 
results obtained with this method and our proposed filter method. To avoid overfitting, 
feature selection was implemented within the model-building process, that is, a 
different ranking of features was obtained in each group using only the training 
samples of each group [40]. The ranked features were progressively added one by 
one from most to least important and then each feature subset was used to tune the 
model parameter (inner 10-fold CV loop), to train the model and to compute the 
metrics on the test samples of the same group. At the end, a total of F=43 sets of 
metrics were obtained in each group evaluation, one per each feature subset. 
Although several metrics were obtained, the relevance of the classification 
results was estimated using the area under receiver operating characteristic curve 
(AUC) averaged over groups’ estimates (mean ± standard deviation). In the 
multiclass strategy, AUC was computed by averaging the one-versus-all statistics, as 
it is a simple way to extend the AUC computation to multiple classes problems [41]. 
The model evaluation process was implemented with the Caret package [42] 




In general, 3D features provided better classification accuracy than 2D 
features in the multiclass strategy, but the number of gray-levels used for 





3D features from the MRI lesions quantized with NGL of 8, 16 and 32 gray-levels 
provided better AUC than the equivalent 2D features. However, for NGL=64, the 
resulting AUC was similar for 3D and 2D features, and for NGL=128, 2D features 
were more discriminative than 3D features. Therefore, 3D features were more 
influenced by the quantization of the MRI regions than 2D features, losing 
discriminative power when increasing NGL. The exact AUC values obtained for the 
10 datasets are shown in Table 1 of the Supplementary Material. 
The highest AUC was achieved using 3D features from the lesions quantized 
with NGL=32, obtaining an AUC = 0.873 ± 0.064 using only the top four features 
ranked with the p-value feature selection method. When using the RF variable 
importance in the classification of this dataset, the features were ranked similarly and 
the results were slightly worse, but comparable (AUC = 0.841 ± 0.074, with 12 
features). 
Table 2 shows that features derived from the GLCM, GLRLM and GLSZM 
topped the ranking with significant p-value (p<10-3). However, the p-value obtained 
with the ANOVA F-test indicated that there was a significant difference between at 
least two of the three classes of BM primary cancers, so additional evaluation of the 
difference between individual groups was needed. 
 
One-versus-one strategy 
 An overall confusion matrix (CM) was obtained for the dataset presenting the 
highest results in the multiclass strategy (3D features, NGL=32) by summing up all 
confusion matrices obtained in every group’s estimate (Table 3). The overall CM 
revealed that lung cancer BM were classified correctly most of the time (82%), but 





 The one-versus-one analysis revealed that it would be possible to differentiate 
precisely lung cancer BM from breast cancer BM (AUC = 0.963 ± 0.054) and 
melanoma BM (AUC = 0.936 ± 0.070) using few features of the optimal dataset (4 
and 8 features respectively). However, poor accuracy was achieved when 
discriminating BM from breast cancer and melanoma (AUC = 0.607 ± 0.180), thus 
indicating that these features are not suitable for classifying those types of BM. 
These results are shown in Figure 4. Additional statistical metrics were computed to 
validate the results (Table 4). 
Regarding the top ranked features, Table 5 shows that the ranking of features 
provided by the multiclass strategy mostly coincided with the rankings computed to 
classify lung cancer BM from breast cancer and melanoma BM. Furthermore, the top 
ten features of both rankings showed significant average p-values (10-8 < p < 10-2). 
However, none of the features showed significant average p-value (p>0.2) when 
classifying BM from breast cancer and melanoma. 
The ranking computed with the RF feature selection method was similar to that 
obtained with our filter method when classifying lung cancer BM from breast cancer 
and melanoma BM, especially in the top-ranked features. On the contrary the ranking 
obtained when classifying breast cancer from melanoma BM was different. When 
performing the classification analysis with this RF ranking we found that the results 
did not differ very much from those results obtained with the p-value method (lung 
cancer versus breast cancer BM: AUC = 0.966 ± 0.052 with 5 features; lung cancer 
versus melanoma BM: AUC = 0.922 ± 0.069 with 10 features; melanoma versus 








The radiomics approach used in this study showed that 3D texture features 
were more suitable than 2D features for classifying lung cancer BM from breast 
cancer and melanoma BM, achieving an average AUC > 0.9 in both cases. Random 
Forest provided better accuracy results when limiting the number of features. The 
results showed that, with further research, TA could help in the identification of the 
primary site of origin in patients with BM from an unknown primary cancer. Also, 
patients with two known primary tumors could benefit from this methodology to find 
which tumor has metastasize to the brain. 
This study extends and improves the preliminary results exposed in [43] and 
[44]. In [43] we analyzed the potential of 2D MRI texture features to classify lung 
cancer BM from breast cancer BM, focusing on the influence of the NGL. In [44], we 
studied the classification of lung cancer and melanoma BM by comparing the 
discrimination power of 2D and 3D MRI texture features and by testing several 
classifiers. In the present study we extended these works by studying the 
differentiation of lung cancer, breast cancer and melanoma BM all together, 
establishing a robust methodology to perform a multiclass classification applicable to 
other primary sites of origin. We also evaluated two feature selection methods, 
studied the influence of the NGL and compared more exhaustively the performance 
of 2D and 3D TA. 
Our work is not the first attempt to differentiate BM by its primary site of origin 
using texture features. Beres et al. [45] studied the statistical significance of 2D and 
3D texture features from the histogram and the GLCM to identify the differences 
between lung and breast cancer BM. Our work enhances this study by exploring 





learning approach. With our results, we support the conclusions of Beres et al. that 
TA may help in the discrimination of BM from different primary tumors. 
We based our work on other similar studies that showed the potential of MRI 
texture features combined with machine learning techniques to classify different brain 
lesions, including BM. Larroza et al. [21] used texture features to distinguish between 
BM and radiation necrosis using a LGOCV structure and support vector machine 
classifier (AUC>0.9). Li et al. [22] used texture features to differentiate BM from 
different pathological types of lung cancers using K-nearest neighbor and back-
propagation artificial neural network classifiers in a one-versus-one approach 
(AUC≥0.9 when differentiating small cell lung carcinoma from other types of lung 
cancers). Both studies showed promising result and were very influential to our work. 
However, we tried to go beyond by including 3D texture features and taking into 
account rotation invariance. 
Several studies have addressed the problem of classifying different brain 
tumor types by analyzing the potential of 3D MRI texture features in comparison with 
2D features [17, 18, 20]. These studies showed an improvement in classification 
accuracy when using 3D TA. The conclusions in these works are clear: 3D texture 
descriptors capture more information about the lesion heterogeneity than 2D 
descriptors. In particular, the study of Fetit et al. [18] is very conclusive on this matter. 
This study mainly compares 2D and 3D texture features with several predictive 
models to classify different childhood brain tumors. All the models worked better with 
3D features: for example, the neural network classifier showed 12% improvement in 
AUC and 19% in overall accuracy when using 3D TA instead of 2D TA. Nevertheless, 
3D TA presents some drawbacks. Firstly, the 3D segmentation of the lesion can be 





Additionally, 3D TA requires MRI scans as isotropic as possible to reduce the effect 
of the image interpolation, and the acquisition process of these scans can be very 
slow. 
The influence of the NGL used in the quantization of MRI has been analyzed 
in some studies with mixed results. No difference was reported by several studies 
[34, 46] when comparing the effect of changing NGL on the texture outcome. 
However, other studies showed that the discriminative power of texture-based 
features were affected by the gray-level quantization. Chen et al. [47] found that the 
optimal results for characterizing breast lesions were achieved for NGL=32. Leite et 
al. [25] observed that quantizing with NGL=16 allowed to identify the etiology of brain 
white matter lesions more accurately. Mahmoud-Ghoneim et al. [26] analyzed the 
impact of varying NGL on GLCM features of brain white matter: they concluded that 
their classification results were influenced significantly by the NGL chosen and they 
obtained better results with NGL=128 for both 2D and 3D TA. Our results support the 
fact that the NGL should be optimized for each specific application because it can 
lead to better classification results. 
Our study showed several limitations. The main limitation was the reduced set 
of BM; more samples would be needed to build and test a final predictive model. 
Also, we only considered metastases derived from the most common primary sites of 
origin; other types of BM like those from renal or colorectal cancer should be 
considered in further analyses because it is necessary to consider all possible sites 
of origin to build a reliable final predictive model. Moreover, we only included MR 
images acquired with the same scanner and imaging parameters since TA can be 
affected by differences in scan parameters; a multicenter study on this specific 





classify breast cancer and melanoma BM, so further investigation will be performed 
by exploring other texture methods like Local Binary Patterns or transform methods 
(Wavelets, Gabor filters…) or other MRI sequences that could capture differences 
between BM from different primary sites of origin. To our knowledge, a genetic or 
pathologic link between breast cancer and melanoma that could be related to these 
TA results is unclear at this point, and the study of this association goes beyond the 
objective of this work. 
In conclusion, our results show that TA on T1-weighted MRI in combination 
with a RF classifier allows differentiating accurately BM of lung cancer origin from 
those of breast cancer and melanoma origin when the proper features are chosen. 
These results are promising but further research is expected to consolidate this 
methodology. Our results support the conclusions derived from other studies to 
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List of texture features used in this study 
 
Method Features Number of Features 
Histogram 
 





Energy, Contrast, Correlation, Homogeneity, Variance, Sum 





Short Run Emphasis (SRE), Long Run Emphasis (LRE), Gray-level 
Non-uniformity (GLN), Run-Length Non-uniformity (RLN), Run 
Percentage (RP), Low Gray-level Run Emphasis (LGRE), High 
Gray-level Run Emphasis (HGRE), Short Run Low Gray-level 
Emphasis (SRLGE), Short Run High Gray-level Emphasis 
(SRHGE), Long Run Low Gray-level Emphasis (LRLGE), Long Run 
High Gray-level Emphasis (LRHGE), Gray-level Variance (GLV) 





Small Zone Emphasis (SZE), Large Zone Emphasis (LZE), Gray-
level Non-uniformity (GLN), Zone-Size Non-uniformity (ZSN), Zone 
Percentage (ZP), Low Gray-level Zone Emphasis (LGZE), High 
Gray-level Zone Emphasis (HGZE), Small Zone Low Gray-level 
Emphasis (SZLGE), Small Zone High Gray-level Emphasis 
(SZHGE), Large Zone Low Gray-level Emphasis (LZLGE), Large 
Zone High Gray-level Emphasis (LZHGE), Gray-level Variance 










GLCM Gray-level co-occurrence matrix, GLRLM Gray-level run-length matrix, 









Top ten features of the dataset with the highest accuracy (3D features, NGL = 32 
gray-levels) ranked according to their average p-value computed with the ANOVA F-
test in the multiclass analysis. 
 
Method Feature Average Ranking Average p-value 
GLCM Variance 1,02 < 10-8 
GLSZM Low Gray-level Zone Emphasis 2,72 < 10-6 
GLCM Sum Average 3,02 < 10-6 
GLSZM Small Zone Low Gray-level Emphasis 3,73 < 10-6 
GLRLM Short Run Low Gray-level Emphasis 5,36 < 10-5 
GLRLM Low Gray-level Run Emphasis 6,72 < 10-5 
GLRLM High Gray-level Run Emphasis 6,86 0.00001 
GLSZM High Gray-level Zone Emphasis 7,37 0.00001 
GLCM Autocorrelation 8,52 0.00004 
GLSZM Gray-level Non-uniformity 10,32 0,00062 
 
The subset of features highlighted in bold provided the highest classification 
accuracy. 
GLCM Gray-level co-occurrence matrix, GLRLM Gray-level run-length matrix, 









Overall CM extracted from the RF model performance using the dataset with the best 












 Breast Cancer 235 (58.75%) 44 (11%) 121 (30.25%) 
Lung Cancer 55 (9.17%) 492 (82%) 53 (8.83%) 









Additional metrics obtained in the one-versus-one analysis using the RF model on 
the best dataset (3D features, NGL = 32 gray-levels). 
 
Primary Site of Origin Lung Cancer vs. Breast Cancer 
Lung Cancer vs. 
Melanoma 
Breast Cancer vs. 
Melanoma 
Number of Features 4 8 42 
Sensitivity a 0,895 ± 0,163 0,867 ± 0,153 0,600 ± 0,258 
Specificity a 0,880 ± 0,132 0,856 ± 0,153 0,496 ± 0,224 
Overall Accuracy 0,862 ± 0,091 0,861 ± 0,092 0,560 ± 0,146 
Kappa Index 0,711 ± 0,192 0,722 ± 0,185 0,097 ± 0,298 
 
Values are shown as mean ± standard deviation as a result over groups’ estimates. 
a Sensitivity and specificity were computed according to the optimal cutoff point of the 







Top ten features of the best dataset (3D features, NGL = 32 gray-levels) ranked 
according to their average p-value computed with the Welch’s t-test in the one-
versus-one analysis. 
 
Lung Cancer vs. 
Breast Cancer 
Lung Cancer vs. 
Melanoma 
Breast Cancer vs. 
Melanoma 





Variance a < 10-7 Variance a < 10-6 Autocorrelation 0,25991 
Sum Average < 10-5 
Low Gray-level 
Zone Emphasis < 10-5 Sum Average 0,27571 
Low Gray-level 
Zone Emphasis < 10-5 





Variance b 0,30066 




Short Run Low 
Gray-level 
Emphasis 
< 10-5 Entropy 0,30861 
High Gray-level 
Zone Emphasis 0.00005 
Low Gray-level 
Run Emphasis 0.00001 Strength 0,32501 
Short Run Low 
Gray-level 
Emphasis 
0,00011 Sum Average 0.00003 Coarseness 0,33500 
Autocorrelation 0,00014 
High Gray-level 
Run Emphasis 0.00007 
High Gray-level 
Zone Emphasis 0,33575 
High Gray-level 
Run Emphasis 0,00016 
High Gray-level 
Zone Emphasis 0,00020 
Gray-level Non-
uniformity b 0,34701 
Low Gray-level 
Run Emphasis 0,00035 
Long Run Low 
Gray-level 
Emphasis 
0,00048 Energy 0,34283 
Gray-level Non-
uniformity b 0,00503 
Gray-level Non-
uniformity b 0,00075 
High Gray-level 
Run Emphasis 0,36704 
 
The features highlighted in bold are in accordance with those features ranked in the 
multiclass analysis. 
a These features are computed from the GLCM (Gray-level co-occurrence matrix) 





Figure 1. Procedure for obtaining the 10 different datasets of features. Examples of 
T1-weighted MRI axial slices showing the most solid area of brain metastases from 
lung cancer origin (a), breast cancer origin (b) and melanoma origin (c) are 
presented. Images were segmented in 2D and 3D, normalized with the µ ± 3σ 
method and quantized using 5 different gray-levels. Then, features were extracted 
and standardized. 
Figure 2. Structure of the nested CV method used to evaluate the different datasets 
of features. All the samples of each dataset were randomly separated in training and 
test sets N=100 times to evaluate the RF model with the AUC, examining different 
subsets of features. 
Figure 3. Comparison between RF model performance using 2D and 3D features for 
all the number of gray-levels considered in this study. The numbers on the curves 
indicate the number of features used to achieve the maximum AUC. 
Figure 4. Average receiver operating characteristics curves obtained in the one-
versus-one analysis. The highlighted points on the curves indicate the optimal cutoff 
points that weighs both sensitivity and specificity equally computed with the “closest-
to-(0,1)” criterion.   
 
 
 
